Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 124

1.

Disorganization at the stage of schizophrenia clinical outcome: Clinical-biological study.

Nestsiarovich A, Obyedkov V, Kandratsenka H, Siniauskaya M, Goloenko I, Waszkiewicz N.

Eur Psychiatry. 2016 Dec 30;42:44-48. doi: 10.1016/j.eurpsy.2016.12.011. [Epub ahead of print]

PMID:
28192769
2.

Genetic Variation in One-Carbon Metabolism and Changes in Metabolic Parameters in First-Episode Schizophrenia Patients.

Misiak B, Łaczmański Ł, Słoka NK, Szmida E, Ślęzak R, Piotrowski P, Kiejna A, Frydecka D.

Int J Neuropsychopharmacol. 2016 Dec 8. pii: pyw094. doi: 10.1093/ijnp/pyw094. [Epub ahead of print]

PMID:
27932499
4.

Cumulative effect of the plasma total homocysteine-related genetic variants on schizophrenia risk.

Kinoshita M, Numata S, Tajima A, Nishi A, Muraki S, Tsuchiya A, Umehara H, Watanabe SY, Imoto I, Ohmori T.

Psychiatry Res. 2016 Dec 30;246:833-837. doi: 10.1016/j.psychres.2016.10.017. Epub 2016 Oct 17.

PMID:
27810229
5.

Genome-Wide Association Study of Loneliness Demonstrates a Role for Common Variation.

Gao J, Davis LK, Hart AB, Sanchez-Roige S, Han L, Cacioppo JT, Palmer AA.

Neuropsychopharmacology. 2017 Mar;42(4):811-821. doi: 10.1038/npp.2016.197. Epub 2016 Sep 15.

PMID:
27629369
6.

Multi-regression analysis revealed a relationship between l-serine and methionine, a component of one-carbon metabolism, in the normal control but not in the schizophrenia.

Takano Y, Ozeki Y, Sekine M, Fujii K, Watanabe T, Okayasu H, Shinozaki T, Aoki A, Akiyama K, Homma H, Shimoda K.

Ann Gen Psychiatry. 2016 Aug 31;15(1):23. doi: 10.1186/s12991-016-0113-3. eCollection 2016 Aug 31.

7.

Effectiveness of add-on l-methylfolate therapy in a complex psychiatric illness with MTHFR C677 T genetic polymorphism.

Jha S, Kumar P, Kumar R, Das A.

Asian J Psychiatr. 2016 Aug;22:74-5. doi: 10.1016/j.ajp.2016.05.007. Epub 2016 May 20.

PMID:
27520898
8.

CT genotype of 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is protector factor of major depressive disorder in the Tunisian population: a case control study.

Sayadi MA, Achour O, Ezzaher A, Hellara I, Omezzine A, Douki W, Bousslama A, Gaha L, Najjar MF.

Ann Gen Psychiatry. 2016 Jul 30;15:18. doi: 10.1186/s12991-016-0103-5. eCollection 2016 Jul 30.

9.

[Stress and psychotic transition: A literature review].

Chaumette B, Kebir O, Mam Lam Fook C, Bourgin J, Godsil BP, Gaillard R, Jay TM, Krebs MO.

Encephale. 2016 Aug;42(4):367-73. doi: 10.1016/j.encep.2015.10.001. Epub 2016 May 6. French.

PMID:
27161263
10.

Metabolic dysregulation in first-episode schizophrenia patients with respect to genetic variation in one-carbon metabolism.

Misiak B, Łaczmański Ł, Słoka NK, Szmida E, Piotrowski P, Loska O, Ślęzak R, Kiejna A, Frydecka D.

Psychiatry Res. 2016 Apr 30;238:60-7. doi: 10.1016/j.psychres.2016.01.077. Epub 2016 Feb 10.

PMID:
27086212
11.

MTHFR genetic testing: Controversy and clinical implications.

Long S, Goldblatt J.

Aust Fam Physician. 2016 Apr;45(4):237-40. Review.

12.

Role of MTHFR C677T gene polymorphism in the susceptibility of schizophrenia: An updated meta-analysis.

Yadav U, Kumar P, Gupta S, Rai V.

Asian J Psychiatr. 2016 Apr;20:41-51. doi: 10.1016/j.ajp.2016.02.002. Epub 2016 Feb 15. Review.

PMID:
27025471
13.

GENETICS OF HUMAN AGE RELATED DISORDERS.

Srivastava I, Thukral N, Hasija Y.

Adv Gerontol. 2015;28(2):228-47. Review.

PMID:
26856084
14.

A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia.

Malan-Müller S, Kilian S, van den Heuvel LL, Bardien S, Asmal L, Warnich L, Emsley RA, Hemmings SM, Seedat S.

Schizophr Res. 2016 Jan;170(1):1-17. doi: 10.1016/j.schres.2015.11.011. Epub 2015 Nov 25. Review.

PMID:
26621002
15.

[One-carbon Metabolism and Schizophrenia].

Kinoshita M.

Seishin Shinkeigaku Zasshi. 2015;117(5):362-8. Japanese.

PMID:
26502713
16.

Evaluation of an association between plasma total homocysteine and schizophrenia by a Mendelian randomization analysis.

Numata S, Kinoshita M, Tajima A, Nishi A, Imoto I, Ohmori T.

BMC Med Genet. 2015 Jul 26;16:54. doi: 10.1186/s12881-015-0197-7.

17.

Endothelial function, folate pharmacogenomics, and neurocognition in psychotic disorders.

Grove T, Taylor S, Dalack G, Ellingrod V.

Schizophr Res. 2015 May;164(1-3):115-21. doi: 10.1016/j.schres.2015.02.006. Epub 2015 Feb 23.

18.

[Association of serum folic acid and homocysteine levels and 5, 10-methylenetetrahydrofolate reductase gene polymorphism with schizophrenia].

Hei G, Pang L, Chen X, Zhang W, Zhu Q, Lü L, Song X.

Zhonghua Yi Xue Za Zhi. 2014 Oct 14;94(37):2897-901. Chinese.

PMID:
25549641
19.

Additive effect of <i>MTHFR</i> and <i>GRIN1</i> genetic polymorphisms on the risk of schizophrenia.

Foroughmand AM, Galehdari H, Pooryasin A, Ajam T, Kazemi-Nezhad SR.

Mol Biol Res Commun. 2015 Jan;4(1):33-42.

20.

The effect of folate supplementation and genotype on cardiovascular and epigenetic measures in schizophrenia subjects.

Ellingrod VL, Grove TB, Burghardt KJ, Taylor SF, Dalack G.

NPJ Schizophr. 2015 Nov 11;1:15046. doi: 10.1038/npjschz.2015.46. eCollection 2015 Nov 11.

Supplemental Content

Loading ...
Support Center